This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
News & Press: Association News

The Association for Vascular Access Announces Adhezion Biomedical as Platinum Industry Partner

Thursday, May 3, 2018  
Share |

The Association for Vascular Access Announces Adhezion Biomedical as Platinum Industry Partner

May 3, 2018 - Today the Association for Vascular Access (AVA) is announcing Adhezion Biomedical, LLC as its newest Platinum Industry Partner, a relationship designed to further enhance the care and management of vascular access.

Creators of the SecurePortIV™ catheter securement adhesive, Adhezion is a leading medical company in the development and manufacture of wound closure and vascular access management products.

“AVA puts a premium on evidence-based innovation in vascular access,” AVA CEO Ramzy Nasrallah said. “Adhezion is supporting research that is proving Tissue Adhesive as an innovative and effective way to care and maintain vascular access device insertion sites. We’re thrilled to have them actively engaged with the AVA community.”

Pennsylvania-based Adhezion has designs on redefining how surgical adhesives and sealants are used in medicine. This aligns with AVA’s mission to Protect the Patient | Educate the Clinician | Save the Line.

“Adhezion is excited to partner with AVA, the organization that uses clinical evidence to define the vascular access standard of care, said Pete Molinaro, Adhezion CEO and Chairman. “Our partnership with AVA is helping us to engage with the leading vascular access experts to further advance tissue adhesive research and to educate clinicians about current research showing how the use of tissue adhesive can improve IV catheter-related outcomes.”

This partnership not only serves clinicians looking for innovative ways to care and maintain for vascular access sites, it keeps the patient at the forefront of the equation, providing publicity to a product designed to reduce the dressing disruption and catheter complications.

“We are thrilled to serve as the vehicle for Adhezion to further its reach in the vascular access space,” AVA Director of Clinical Education Judy Thompson said. “Partnering with Adhezion at a Platinum level allows AVA to take another step forward in our desire to reduce the risk and discomfort associated with vascular access procedures.”

AVA’s Industry Partnership Program is reserved for manufacturers, pharmaceutical companies, infusion providers, home health agencies, government agencies, distributors and other entities interested in enhancing the care and management of vascular access through a multidisciplinary team effort. For more details on AVA’s Industry Partnership Program and its benefits, please visit


The Association for Vascular Access (AVA) was founded in 1985 to promote the emerging vascular access specialty. Today, AVA stands at the forefront of protecting and saving lives via establishing best practices and promoting patient advocacy.  AVA’s multidisciplinary membership advances research, provides professional and public education to shape practice and enhance patient outcomes, and partners with the device manufacturing community to bring about evidence-based innovations in vascular access. To learn more or join, visit 

Adhezion Biomedical, LLC is a privately held medical device company based in Wyomissing, PA. Adhezion is committed to developing and manufacturing medical cyanoacrylate products used in the treatment of wound closure, wound management, intravenous device securement and infection prevention. To learn more about Adhezion and its products, please visit